Osang Healthcare, a company specializing in in vitro diagnostics, has set its initial public offering (IPO) price at 20,000 won, exceeding the upper limit of its target range.

Osang Healthcare announced on the 29th that it had set its IPO price at 20,000 won, exceeding the upper limit of its target range (13,000-15,000 won), based on the results of a demand forecast conducted from the 21st to the 27th targeting domestic and foreign institutional investors.

Full article : Osang Healthcare sets public offering price at 20,000 won, exceeding upper limit of target range - Chosun Biz